Your browser doesn't support javascript.
loading
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
Badodi, Sara; Pomella, Nicola; Lim, Yau Mun; Brandner, Sebastian; Morrison, Gillian; Pollard, Steven M; Zhang, Xinyu; Zabet, Nicolae Radu; Marino, Silvia.
Afiliación
  • Badodi S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Pomella N; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Lim YM; UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Brandner S; UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Morrison G; Centre for Regenerative Medicine & Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK.
  • Pollard SM; Centre for Regenerative Medicine & Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK.
  • Zhang X; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Zabet NR; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Marino S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Neuro Oncol ; 24(8): 1273-1285, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35213723
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias Cerebelosas / Inhibidores de Proteínas Quinasas / Meduloblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias Cerebelosas / Inhibidores de Proteínas Quinasas / Meduloblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido